Trial Details
UNKNOWNBasic Information
| Clinical ID | c1636 |
|---|---|
| Identifier | NCT01817972 |
| Trial Title | Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Certolizumab pegol|DRUG: Azathioprine |
Participant Information
| Sponsor | Gastroenterology Research of America |
|---|---|
| City | San Antonio |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-03-13 |
|---|---|
| Primary Completion Date | 2025-06-14 |
| Completion Date | 2025-11-14 |